Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Lorcaserin is a newly developed US weight-loss drug, designed for chronic weight management in adult patients with a body mass index from 27 to 30. According to clinical trials carried out on the lorcaserin drug, it not only reduces adiposity but also improves the metabolic diseases commonly associated with adiposopathy. Recently, the US Food and Drug Administration announced its approval, and released it on the market of the weight-loss medication, under the commercial name Belviq. Learn more about the anti-obesity drug in this book.